Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Dr Billy Franks explains the importance of data analysis plans for PIONEER’s research questions

Dr Billy Franks - Astellas Pharma B.V.
Dr Billy Franks explains the importance of data analysis plans for PIONEER’s research questions ( Dr Billy Franks - Astellas Pharma B.V. )
13 May 2019

Prof Anders Bjartell discusses the data sources and access of the PIONEER data models

Prof Anders Bjartell - Skåne University Hospital, Malmö, Lund University, Sweden
Prof Anders Bjartell discusses the data sources and access of the PIONEER data models ( Prof Anders Bjartell - Skåne University Hospital, Malmö, Lund University, Sweden )
13 May 2019

Dr Alex Asiimwe, EFPIA lead for PIONEER, discusses the unique public-private aspects of BD4BO

Dr Alex Asiimwe - Director, BAYER AG, Medical affairs, Epidemiology
Dr Alex Asiimwe, EFPIA lead for PIONEER, discusses the unique public-private aspects of BD4BO ( Dr Alex Asiimwe - Director, BAYER AG, Medical affairs, Epidemiology )
13 May 2019

Controversies in the management of prostate cancer

Prof Mach Roach III - University of California, San Francisco, USA
Controversies in the management of prostate cancer ( Prof Mach Roach III - University of California, San Francisco, USA )
9 May 2019

Local treatment in oligometastatic prostate cancer: Radiotherapy

Prof Mach Roach III - University of California, San Francisco, USA
Local treatment in oligometastatic prostate cancer: Radiotherapy ( Prof Mach Roach III - University of California, San Francisco, USA )
9 May 2019

SBRT photons, protons or carbon for prostate cancer: How good is the data?

Prof Mach Roach III - University of California, San Francisco, USA
SBRT photons, protons or carbon for prostate cancer: How good is the data? ( Prof Mach Roach III - University of California, San Francisco, USA )
9 May 2019

Differences in hormone therapy for patients with advanced metastatic prostate cancer

Prof Axel Merseburger - University Hospital Schleswig-Holstein, Lübeck, Germany
Differences in hormone therapy for patients with advanced metastatic prostate cancer ( Prof Axel Merseburger - University Hospital Schleswig-Holstein, Lübeck, Germany )
9 May 2019

State of art in systemic management of nmCRPC

Prof Stéphane Oudard - Georges Pompidou Hospital, Paris, France
State of art in systemic management of nmCRPC ( Prof Stéphane Oudard - Georges Pompidou Hospital, Paris, France )
8 May 2019

EAU prostate cancer guidelines 2019: What changed and why?

Prof Nicolas Mottet - University Hospital St Etienne, St Etienne, France
EAU prostate cancer guidelines 2019: What changed and why? ( Prof Nicolas Mottet - University Hospital St Etienne, St Etienne, France )
8 May 2019

Neoadjuvant treatment before radical prostatectomy: Current situation

Prof Nicolas Mottet - University Hospital St Etienne, St Etienne, France
Neoadjuvant treatment before radical prostatectomy: Current situation ( Prof Nicolas Mottet - University Hospital St Etienne, St Etienne, France )
8 May 2019

Emerging management of metastatic castration-sensitive prostate cancer: front-line chemotherapy vs. oral therapy

Prof Jorge A. Garcia - Cleveland Clinic, Cleveland, USA
Emerging management of metastatic castration-sensitive prostate cancer: front-line chemotherapy vs. oral therapy ( Prof Jorge A. Garcia - Cleveland Clinic, Cleveland, USA )
8 May 2019

First- and second-line treatments for locally advanced renal cell carcinoma

Prof Jorge A. Garcia - Cleveland Clinic, Cleveland, USA
First- and second-line treatments for locally advanced renal cell carcinoma ( Prof Jorge A. Garcia - Cleveland Clinic, Cleveland, USA )
8 May 2019